Cutaneous T-cell lymphoma stage I

Clinical trials for Cutaneous T-cell lymphoma stage I explained in plain language.

Never miss a new study

Get alerted when new Cutaneous T-cell lymphoma stage I trials appear

Sign up with your email to follow new studies for Cutaneous T-cell lymphoma stage I, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Pairing a steroid with lymphoma gel may prevent painful skin reactions

Disease control Completed

This phase 2 trial tests whether adding triamcinolone 0.1% ointment to Valchlor gel reduces contact dermatitis, a common skin reaction, in people with early-stage cutaneous T-cell lymphoma. Participants apply Valchlor nightly, with or without the steroid up to three times daily, …

Matched conditions: CUTANEOUS T-CELL LYMPHOMA STAGE I

Phase 2 • Sponsor: Rochester Skin Lymphoma Medical Group, PLLC • Aim: Disease control

Last updated Sep 06, 2026 00:00 UTC

Cutaneous T-cell lymphoma stage I

Get alerted when new Cutaneous T-cell lymphoma stage I trials appear

Pairing a steroid with lymphoma gel may prevent painful skin reactions